Effects of Emotional Processes on Speech Motor Control in Early Childhood Stuttering. (NCT05003583) | Clinical Trial Compass
CompletedNot Applicable
Effects of Emotional Processes on Speech Motor Control in Early Childhood Stuttering.
United States68 participantsStarted 2021-05-21
Plain-language summary
This study will compare speech variability between preschool-age children who stutter and typically fluent, age-matched peers. Differences in emotional reactivity, regulation and speech motor control have been implicated in stuttering development in children. This study seeks to understand further how these processes interact. Children will repeat a simple phrase after viewing age-appropriate images of either negative or neutral valence to assess speech motor control.
Who can participate
Age range
3 Years – 10 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. English as the primary language of communication.
. No history of neurological diseases or diagnosed speech-language disorders apart from stuttering.
. Parent report or direct observation of oral-facial structural abnormalities (such as cleft lip and/or cleft palate).
. Free of any medications that may affect neural functions (e.g., medications of seizures).
. Normal hearing acuity (must pass a hearing screening).
. Normal vision per parent report.
Exclusion criteria
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
The spatiotemporal index (STI) of lip aperture during a negative valence condition on Day 1 (pretest).
Timeframe: through study completion, an average of 3 weeks
2
The spatiotemporal index (STI) of lip aperture during a neutral valence condition on Day 1 (pretest).
Timeframe: through study completion, an average of 3 weeks
3
The spatiotemporal index (STI) of lip aperture during a negative valence condition on Day 2 (retention).
Timeframe: through study completion, an average of 3 weeks
4
The spatiotemporal index (STI) of lip aperture during a neutral valence condition on Day 2 (retention).
Timeframe: through study completion, an average of 3 weeks